 Ronald Freund
Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long-Term Potentiation | 11 | 2024 | 198 | 1.550 |
Why?
| | Hippocampus | 22 | 2024 | 895 | 1.360 |
Why?
| | Ethanol | 14 | 2012 | 608 | 1.070 |
Why?
| | Cerebellum | 8 | 2012 | 224 | 0.980 |
Why?
| | Amyloid beta-Peptides | 3 | 2024 | 221 | 0.760 |
Why?
| | Dendritic Spines | 3 | 2024 | 65 | 0.710 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 5 | 2024 | 188 | 0.700 |
Why?
| | Mice, Inbred C3H | 5 | 2016 | 269 | 0.600 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 6 | 2024 | 221 | 0.570 |
Why?
| | Purkinje Cells | 10 | 2003 | 70 | 0.510 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2016 | 97 | 0.490 |
Why?
| | Calcineurin | 3 | 2024 | 108 | 0.480 |
Why?
| | A Kinase Anchor Proteins | 3 | 2024 | 72 | 0.480 |
Why?
| | Amyloid | 1 | 2016 | 88 | 0.470 |
Why?
| | Long-Term Synaptic Depression | 4 | 2024 | 56 | 0.450 |
Why?
| | Nicotine | 7 | 1997 | 336 | 0.440 |
Why?
| | Neurons | 9 | 2016 | 1588 | 0.420 |
Why?
| | Mice, Inbred C57BL | 9 | 2024 | 5753 | 0.400 |
Why?
| | Peptide Fragments | 2 | 2016 | 707 | 0.390 |
Why?
| | Enzyme Inhibitors | 1 | 2016 | 839 | 0.390 |
Why?
| | Central Nervous System Depressants | 4 | 2011 | 85 | 0.380 |
Why?
| | gamma-Aminobutyric Acid | 7 | 2006 | 198 | 0.360 |
Why?
| | In Vitro Techniques | 13 | 2016 | 1089 | 0.320 |
Why?
| | Receptors, GABA-A | 4 | 2022 | 142 | 0.300 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2021 | 135 | 0.300 |
Why?
| | Receptors, Adrenergic, beta | 4 | 1997 | 127 | 0.300 |
Why?
| | Receptors, AMPA | 3 | 2021 | 141 | 0.280 |
Why?
| | Animals | 42 | 2024 | 36862 | 0.250 |
Why?
| | Synapses | 5 | 2023 | 427 | 0.240 |
Why?
| | Norepinephrine | 2 | 2003 | 204 | 0.230 |
Why?
| | Calcium | 3 | 2023 | 1198 | 0.230 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2024 | 40 | 0.220 |
Why?
| | Species Specificity | 5 | 2016 | 585 | 0.200 |
Why?
| | Phosphorylation | 8 | 2024 | 1759 | 0.200 |
Why?
| | Rats | 21 | 2014 | 5639 | 0.190 |
Why?
| | Mice | 21 | 2024 | 17774 | 0.190 |
Why?
| | Synaptic Transmission | 4 | 2006 | 289 | 0.190 |
Why?
| | Neuronal Plasticity | 3 | 2023 | 290 | 0.190 |
Why?
| | Calcium Channels, L-Type | 1 | 2022 | 118 | 0.180 |
Why?
| | Action Potentials | 7 | 2012 | 495 | 0.180 |
Why?
| | Receptors, Nicotinic | 2 | 1997 | 335 | 0.180 |
Why?
| | Rats, Sprague-Dawley | 13 | 2014 | 2486 | 0.170 |
Why?
| | Second Messenger Systems | 2 | 1997 | 31 | 0.170 |
Why?
| | Mice, Inbred DBA | 6 | 1990 | 200 | 0.160 |
Why?
| | Mecamylamine | 3 | 1997 | 9 | 0.140 |
Why?
| | Receptors, GABA | 1 | 1997 | 14 | 0.140 |
Why?
| | Bicuculline | 4 | 2008 | 23 | 0.130 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1996 | 21 | 0.130 |
Why?
| | Glutamic Acid | 4 | 2023 | 248 | 0.130 |
Why?
| | Thiones | 1 | 2016 | 14 | 0.130 |
Why?
| | Cyclic AMP | 1 | 1997 | 234 | 0.130 |
Why?
| | Sensory Gating | 1 | 2016 | 45 | 0.120 |
Why?
| | Kinetics | 3 | 2016 | 1674 | 0.110 |
Why?
| | Acoustic Stimulation | 1 | 2016 | 316 | 0.110 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2014 | 37 | 0.110 |
Why?
| | Leukotrienes | 1 | 2014 | 37 | 0.110 |
Why?
| | Electric Stimulation | 7 | 2012 | 264 | 0.110 |
Why?
| | Learning | 2 | 2023 | 415 | 0.110 |
Why?
| | Signal Transduction | 2 | 2024 | 5078 | 0.100 |
Why?
| | Excitatory Postsynaptic Potentials | 4 | 2021 | 124 | 0.100 |
Why?
| | Pyrimidines | 1 | 2016 | 471 | 0.100 |
Why?
| | Male | 23 | 2024 | 67560 | 0.090 |
Why?
| | Mice, Transgenic | 4 | 2024 | 2164 | 0.090 |
Why?
| | CA1 Region, Hippocampal | 2 | 2022 | 52 | 0.090 |
Why?
| | Cells, Cultured | 3 | 2016 | 4197 | 0.090 |
Why?
| | Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2011 | 11 | 0.090 |
Why?
| | Mice, Knockout | 2 | 2016 | 3009 | 0.090 |
Why?
| | Synaptic Potentials | 1 | 2011 | 17 | 0.090 |
Why?
| | Indoles | 1 | 2014 | 410 | 0.090 |
Why?
| | Mice, Inbred Strains | 2 | 2006 | 409 | 0.090 |
Why?
| | Electroencephalography | 1 | 1993 | 433 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2014 | 515 | 0.080 |
Why?
| | Phosphoserine | 4 | 2014 | 34 | 0.080 |
Why?
| | Brain Injuries | 1 | 2014 | 493 | 0.080 |
Why?
| | Protein Binding | 3 | 2024 | 2225 | 0.080 |
Why?
| | Memory | 1 | 2010 | 255 | 0.070 |
Why?
| | Seizures | 3 | 1990 | 430 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2010 | 2052 | 0.070 |
Why?
| | Fear | 1 | 2011 | 338 | 0.070 |
Why?
| | Corticosterone | 1 | 1988 | 236 | 0.070 |
Why?
| | Female | 14 | 2024 | 73052 | 0.070 |
Why?
| | Glutamates | 2 | 1984 | 59 | 0.070 |
Why?
| | Fetal Tissue Transplantation | 2 | 1997 | 35 | 0.060 |
Why?
| | Patch-Clamp Techniques | 3 | 2012 | 286 | 0.060 |
Why?
| | Isoproterenol | 3 | 1994 | 113 | 0.060 |
Why?
| | Nomifensine | 1 | 2003 | 4 | 0.050 |
Why?
| | Evoked Potentials | 3 | 1993 | 126 | 0.050 |
Why?
| | Spinal Cord | 2 | 1997 | 370 | 0.050 |
Why?
| | Microelectrodes | 1 | 2003 | 45 | 0.050 |
Why?
| | Electrochemistry | 1 | 2003 | 79 | 0.050 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2003 | 59 | 0.050 |
Why?
| | Syndactyly | 1 | 2022 | 9 | 0.050 |
Why?
| | Optogenetics | 1 | 2023 | 108 | 0.050 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2021 | 15 | 0.050 |
Why?
| | Spermine | 1 | 2021 | 27 | 0.050 |
Why?
| | Receptors, Glutamate | 1 | 2021 | 25 | 0.050 |
Why?
| | Long QT Syndrome | 1 | 2022 | 70 | 0.050 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2001 | 72 | 0.040 |
Why?
| | Brain Tissue Transplantation | 1 | 2001 | 19 | 0.040 |
Why?
| | Nerve Degeneration | 1 | 2001 | 46 | 0.040 |
Why?
| | Subcellular Fractions | 2 | 2012 | 82 | 0.040 |
Why?
| | Substantia Nigra | 1 | 2001 | 57 | 0.040 |
Why?
| | Immunoprecipitation | 2 | 2012 | 155 | 0.040 |
Why?
| | Neural Inhibition | 2 | 2010 | 169 | 0.040 |
Why?
| | Quinoxalines | 2 | 2012 | 66 | 0.040 |
Why?
| | N-Methylaspartate | 2 | 2012 | 40 | 0.040 |
Why?
| | Autistic Disorder | 1 | 2022 | 204 | 0.040 |
Why?
| | Iontophoresis | 2 | 1997 | 13 | 0.040 |
Why?
| | Antibody Affinity | 1 | 1999 | 60 | 0.040 |
Why?
| | Corpus Striatum | 1 | 2001 | 167 | 0.040 |
Why?
| | Germinal Center | 1 | 1999 | 58 | 0.040 |
Why?
| | Benzylamines | 2 | 2010 | 41 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 234 | 0.040 |
Why?
| | GABA Antagonists | 2 | 2008 | 35 | 0.040 |
Why?
| | Electrophysiology | 4 | 1997 | 217 | 0.030 |
Why?
| | Stilbamidines | 1 | 1997 | 10 | 0.030 |
Why?
| | GABA Modulators | 1 | 1997 | 12 | 0.030 |
Why?
| | Receptor, IGF Type 1 | 1 | 1997 | 65 | 0.030 |
Why?
| | Mutation | 2 | 2022 | 3956 | 0.030 |
Why?
| | Graft Survival | 2 | 1997 | 534 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 1997 | 77 | 0.030 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2904 | 0.030 |
Why?
| | Aminobutyrates | 3 | 1985 | 35 | 0.030 |
Why?
| | Transplantation, Heterotopic | 1 | 1994 | 18 | 0.030 |
Why?
| | Phosphoproteins | 1 | 1997 | 338 | 0.030 |
Why?
| | Maze Learning | 1 | 2014 | 103 | 0.030 |
Why?
| | Serine | 2 | 2012 | 141 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2014 | 2147 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2014 | 384 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2012 | 13 | 0.030 |
Why?
| | Silver Staining | 1 | 2012 | 17 | 0.030 |
Why?
| | Behavior, Animal | 2 | 2010 | 497 | 0.030 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2012 | 19 | 0.020 |
Why?
| | Epilepsy | 2 | 1987 | 332 | 0.020 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2012 | 39 | 0.020 |
Why?
| | Sodium Channel Blockers | 1 | 2012 | 24 | 0.020 |
Why?
| | Tetrodotoxin | 1 | 2012 | 37 | 0.020 |
Why?
| | Interneurons | 1 | 1993 | 122 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2012 | 100 | 0.020 |
Why?
| | Biophysics | 1 | 2012 | 69 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2022 | 4284 | 0.020 |
Why?
| | Brain | 2 | 2014 | 2675 | 0.020 |
Why?
| | Amnesia | 1 | 2011 | 43 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 1012 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2014 | 532 | 0.020 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 17 | 0.020 |
Why?
| | Pyramidal Tracts | 1 | 1990 | 31 | 0.020 |
Why?
| | Atropine | 1 | 1990 | 23 | 0.020 |
Why?
| | Bungarotoxins | 1 | 1990 | 46 | 0.020 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 21 | 0.020 |
Why?
| | Nicotinic Antagonists | 1 | 1990 | 34 | 0.020 |
Why?
| | Apoptosis | 1 | 1999 | 2554 | 0.020 |
Why?
| | Pregnanolone | 1 | 1990 | 37 | 0.020 |
Why?
| | Depression, Chemical | 2 | 1993 | 23 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1318 | 0.020 |
Why?
| | Conditioning, Classical | 1 | 2010 | 102 | 0.020 |
Why?
| | Phenanthrolines | 1 | 2008 | 7 | 0.020 |
Why?
| | Flurazepam | 1 | 1988 | 1 | 0.020 |
Why?
| | Biophysical Phenomena | 1 | 2008 | 64 | 0.020 |
Why?
| | Mice, Inbred A | 1 | 1988 | 49 | 0.020 |
Why?
| | Flunitrazepam | 1 | 1988 | 3 | 0.020 |
Why?
| | Allylglycine | 1 | 1988 | 2 | 0.020 |
Why?
| | Anticonvulsants | 1 | 1990 | 216 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1988 | 118 | 0.020 |
Why?
| | Ataxia | 2 | 1999 | 44 | 0.020 |
Why?
| | Tyrosine | 1 | 2008 | 222 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 1988 | 170 | 0.020 |
Why?
| | Protein Subunits | 1 | 2008 | 239 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2008 | 111 | 0.020 |
Why?
| | Body Temperature | 1 | 1988 | 221 | 0.020 |
Why?
| | Drug Tolerance | 2 | 1999 | 105 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 664 | 0.020 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2008 | 172 | 0.020 |
Why?
| | Rats, Inbred Strains | 2 | 1985 | 362 | 0.020 |
Why?
| | Protein Transport | 1 | 2008 | 444 | 0.020 |
Why?
| | Reference Values | 1 | 1988 | 818 | 0.020 |
Why?
| | Phosphinic Acids | 1 | 2006 | 9 | 0.020 |
Why?
| | Receptors, GABA-B | 1 | 2006 | 11 | 0.020 |
Why?
| | Sulfonamides | 1 | 2010 | 512 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2012 | 1163 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2010 | 769 | 0.020 |
Why?
| | Psychomotor Performance | 1 | 1988 | 313 | 0.020 |
Why?
| | Ophthalmologic Surgical Procedures | 2 | 1997 | 58 | 0.010 |
Why?
| | Neural Pathways | 2 | 1984 | 295 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1987 | 345 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 1994 | 1709 | 0.010 |
Why?
| | Time Factors | 2 | 1997 | 6818 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 916 | 0.010 |
Why?
| | Sleep | 2 | 2006 | 755 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1984 | 574 | 0.010 |
Why?
| | Drug Synergism | 2 | 1994 | 383 | 0.010 |
Why?
| | Immunohistochemistry | 2 | 1997 | 1734 | 0.010 |
Why?
| | Apomorphine | 1 | 2001 | 7 | 0.010 |
Why?
| | Oxidopamine | 1 | 2001 | 17 | 0.010 |
Why?
| | Sympatholytics | 1 | 2001 | 15 | 0.010 |
Why?
| | Antiparkinson Agents | 1 | 2001 | 28 | 0.010 |
Why?
| | Parkinsonian Disorders | 1 | 2001 | 35 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 2001 | 264 | 0.010 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1999 | 11 | 0.010 |
Why?
| | Antibody-Producing Cells | 1 | 1999 | 30 | 0.010 |
Why?
| | bcl-X Protein | 1 | 1999 | 43 | 0.010 |
Why?
| | Immunoglobulin Variable Region | 1 | 1999 | 80 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 1999 | 150 | 0.010 |
Why?
| | Desipramine | 1 | 1999 | 9 | 0.010 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 1999 | 17 | 0.010 |
Why?
| | B-Lymphocyte Subsets | 1 | 1999 | 75 | 0.010 |
Why?
| | Locus Coeruleus | 1 | 1999 | 23 | 0.010 |
Why?
| | Transgenes | 1 | 1999 | 180 | 0.010 |
Why?
| | Bone Marrow Cells | 1 | 1999 | 316 | 0.010 |
Why?
| | Antibody Formation | 1 | 1999 | 298 | 0.010 |
Why?
| | Naloxone | 1 | 1999 | 120 | 0.010 |
Why?
| | 14-3-3 Proteins | 1 | 1997 | 18 | 0.010 |
Why?
| | Phosphopeptides | 1 | 1997 | 20 | 0.010 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 1997 | 59 | 0.010 |
Why?
| | Antibodies | 1 | 1999 | 412 | 0.010 |
Why?
| | Spleen | 1 | 1999 | 514 | 0.010 |
Why?
| | Receptor, Insulin | 1 | 1997 | 105 | 0.010 |
Why?
| | Antibody Specificity | 1 | 1997 | 189 | 0.010 |
Why?
| | Neurofilament Proteins | 1 | 1997 | 52 | 0.010 |
Why?
| | Narcotic Antagonists | 1 | 1999 | 178 | 0.010 |
Why?
| | Recovery of Function | 1 | 2001 | 657 | 0.010 |
Why?
| | Substance Withdrawal Syndrome | 1 | 1999 | 179 | 0.010 |
Why?
| | Cell Count | 1 | 1997 | 323 | 0.010 |
Why?
| | Humans | 2 | 2024 | 137294 | 0.010 |
Why?
| | Cell Survival | 1 | 1999 | 1119 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 1997 | 318 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1994 | 97 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 1994 | 232 | 0.010 |
Why?
| | Binding Sites | 1 | 1997 | 1309 | 0.010 |
Why?
| | Fibroblasts | 1 | 1997 | 993 | 0.010 |
Why?
| | Cell Differentiation | 1 | 1999 | 1987 | 0.010 |
Why?
| | Depression | 1 | 1999 | 1408 | 0.000 |
Why?
| | 3-Mercaptopropionic Acid | 1 | 1988 | 7 | 0.000 |
Why?
| | Biomarkers | 1 | 1997 | 4164 | 0.000 |
Why?
| | Pregnancy | 1 | 1997 | 6743 | 0.000 |
Why?
| | Chemistry | 1 | 1983 | 45 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1983 | 83 | 0.000 |
Why?
| | Homocysteine | 1 | 1983 | 156 | 0.000 |
Why?
|
|
Freund's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|